Christine Stanley

Christine Stanley is the Chief Director Clinical Genomics at Variantyx. Christine has over 25 years of experience in the field of clinical genomics. Christine has worked at several renowned companies including C2i Genomics, WuXi NextCODE, Courtagen Life Sciences, Inc., and Athena Diagnostics. Christine has also held teaching positions at Virginia Commonwealth University and Protutors.

Christine Stanley has a postdoctoral fellowship in clinical molecular genetics from Boston University School of Medicine, a PhD in human genetics from Virginia Commonwealth University School of Medicine, a PhD in human genetics and genetics from Medical College of Virginia, Virginia Commonwealth University, and a BS in genetics from Texas A&M University. Christine is certified by the American Board of Medical Specialties in diplomate American Board of Medical Genetics (ABMG) and by the New York State Department of Health (NYS DOH) in certificate of qualification, molecular genetic testing.

Their manager is Haim Neerman, CEO. They are on a team with Stephanie Zichi - VP of Marketing, Christopher Zerwas - VP Sales, and Edward J. Sitar - CFO.